Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20200266
    Release date: 28 April 2020

    Promoter – Financial Intermediary

    GALENICUM HEALTH SL

    Location

    Description

    The project will finance the promoter's pharmaceutical RDI and expansion investments in Spain.

    Objectives

    The EIB loan will be used to support the implementation of the company's strategy. The investments are expected to support the promoter's competitiveness and growth.

    Sector(s)

    Proposed EIB finance (Approximate amount)

    EUR 20 million

    Total cost (Approximate amount)

    EUR 50 million

    Environmental aspects

    All aspects related to the environmental impact and permits will be verified during the project's appraisal.

    Procurement

    The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, thus not being subject to EU rule on public procurement.

    Status

    Signed - 14/01/2021

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Spain Industry